Relapsed, Refractory Follicular Lymphoma: CAR-T Cell Therapy Shows Promise
Axicabtagene ciloleucel (axi-cel) appears to be both safe and effective for treating relapsed/refractory follicular lymphoma (FL), according to research presented
Read MoreAxicabtagene ciloleucel (axi-cel) appears to be both safe and effective for treating relapsed/refractory follicular lymphoma (FL), according to research presented
Read MoreIf you have post-traumatic stress disorder (PTSD), you know how much it can mess with your day-to-day life. But help is available.
Read MoreBiopharmaceutical lifecycle management platform IDBS (Guildford, UK) has announced a strategic partnership with software provider Scitara (MA, USA) to provide
Read MoreAmong patients with diffuse large B cell lymphoma (DLBCL) and other non-Hodgkin B cell lymphomas (B-NHLs), naratuximab emtansine appears to
Read MoreQuantum advantage is a hot topic, with multiple experiments approaching (and some even surpassing) the point at which a quantum technology performs better
Read MoreAntibody titer responses to a single dose of mRNA vaccine were higher in health care workers (HCWs) with previous SARS-CoV-2
Read MoreJune is Men’s Health Month, a national observance to raise awareness about healthcare for men and focus on encouraging boys,
Read MoreProfessor David Barrett, lead consultant at Southampton University Hospital and Professor of Orthopedic Engineering, and one of the design surgeons
Read MoreIn a review of 29 randomized controlled trials evaluating HFNO vs noninvasive ventilation (NIV), the ACP found HFNO was slightly
Read More[ad_1] Managing symptoms is an ongoing challenge for chronically ill patients. Whether they’re caused by an exacerbation, disease progression, or
Read More